Otto Meyerhofer Prize for Katharina Höfer
RTG 2355 PI Katharina Höfer was recently awarded the Otto Meyerhof Prize of the German Society for Biochemistry and Molecular Biology (GBM). The prize is allocated bi-anually to an outstanding young scientist who obtained his or her doctorate no longer than 8 years ago at the time of application and who is currently conducting research in Germany; it is endowed with 5.000 € founded by Boehringer Ingelheim Pharma.
Katharina Höfer studied Life Sciences at the Leibniz University Hannover and Molecular Biotechnology at Heidelberg University where she afterwards continued as a doctoral and post-doctoral researcher. Since 2020, she and her Max Planck Research Group "Bacterial Epitranscriptomics" investigate RNA modifications in bacteria and bacteriophages at the Max Planck Institute for Terrestrial Microbiology in Marburg, focussing not only on basic research, but also taking into accout possible future applications.
Within the RTG, Katharina Höfer and doctoral candidate Helene Keuthen characterize molecular mechanisms that regulate RNA stability during infection of Escherichia coli with T4 phage.
